Open-label placebo works as well as double-blind placebo in irritable bowel syndrome

(Beth Israel Deaconess Medical Center) In a randomized clinical trial published in the journal PAIN, researchers found participants with moderate to severe irritable bowel syndrome (IBS) who were knowingly treated with a pharmacologically inactive pill -- referred to as an honest or open-label placebo -- reported clinically meaningful improvements in their IBS symptoms.

https://www.eurekalert.org/pub_releases/2021-03/bidm-opw033021.php

Source: EurekAlert! - Medicine and Health - March 30, 2021 Category: International Medicine & Public Health Source Type: news